Efficacy and Adverse Effects of Nintetanib in Clinical Trials

This chapter reviews clinical trial findings on nintetanib for treating Idiopathic Pulmonary Fibrosis, focusing on its efficacy in reducing FVC decline compared to placebo. It also examines the drug's adverse effects, particularly gastrointestinal issues, along with practical insights into patient management and post-marketing study results.